4th World Congress on Bioavailabity and Bioequivalence Pharmaceutical R & D Summit
May 20-22, 2013 Beijing, China

Upcoming Conference

Home seperator ABOUT seperator OPEN ACCESS seperator CONFERENCES seperator JOURNALS seperator FAQs seperator CONTACT
BABE-2013
Home
Gallery
BABE-2013 Report

4th World Congress on Bioavailability and Bioequivalence: Pharmaceutical R&D Summit, hosted by the OMICS Group was successfully held during May 20-22, 2013 in Beijing, China. Outstanding response and active participation was received from the Researchers, Leaders from Pharmaceutical R&D sectors, Government Organizations, and Principal Investigators. Editorial Board Members of OMICS Group helped in making this meeting a huge success. 

Keynote Speakers:

  • Michael Retsky, Harvard School of Public Health, USA
  • Yibin Feng, The University of Hong Kong, China
  • Shein-Chung Chow, Duke University School of Medicine, USA
  • Sinerik Ayrapetyan, UNESCO, Armenia

A series of invited lectures by Honorable guests and members of the Keynote forum marked the commencement of the event. Keynote session was very prolific to the scientific community and they lifted up solutions and illustrated a way on the theme Advanced Discussions of the Current Issues & Analyzing the Novel Approaches of Bioavailability & Bioequivalence"

Scientific sessions established active contribution from researchers and principal investigators, and the Poster presentations were phenomenally excellent with the enthusiastic students and fellow researchers. It established a new prospect and hopes on ongoing projects in Bioavailability and Bioequivalence and paved a new path to Pharmaceutical R&D.

OMICS Group felicitated all the Organizing Committee Members and Editorial Board Members who enthusiastically participated in the conference and made this meeting a huge success.

OMICS Group on behalf of OCMs and EBMs congratulates all the Best Poster Awardees for their outstanding contribution in the field of Pharmaceutics and simultaneously encourages all the participants who tried to put their efforts in poster presentations and wish them success for their future research.

Best Poster Awardees:

  • Ning Wang, The University of Hong Kong, China
  • Liberato Brum Junior, Prati-donaduzzi Pharmaceutical Industry Co., Ltd., Brazil
  • Syed Naseeruddin Alvi, King Faisal Specialist Hospital and Research Centre, Saudi Arabia
  • Shanmugam, JSS College of Pharmacy, India
  • L. Priyanka Dwarampudi, JSS College of Pharmacy, India

BABE-2013 Organizing Committee Members hearts fully thank all the supporters and media partners in promotion of the conference.

With the huge optimistic response from scientific fraternity, industries, renowned personalities and Editorial Board Members of OMICS Group across the world, we would like to proudly announce

“5th World Congress on Bioavailability and Bioequivalence: Pharmaceutical R&D Summit” during Sep 29 - Oct 01, 2014 in Baltimore, USA

 

We wish to pioneer a way to another outstanding event in USA.



Expert Presentations
Michael Retsky

Harvard School of Public Health

USA
Yibin Feng

The University of Hong Kong

China
Sinerik Ayrapetyan

UNESCO

Armenia
Shein-Chung Chow

Duke University School of Medicine

USA
Guo Ruichen

Shandong University

China
Ping Ren

CDER/FDA

USA
Yahdiana Harahap

University of Indonesia

Indonesia
Amalia S. F. Megremi

University of Athens

Greece
Shunlin Ren

Virginia Commonwealth University

USA
John A. Loudon

Wetherill Park Medical Centre

Australia
Hu Yan

Zhengzhou University

China
Shengjun Zhang

Frontage China Clinical Services

China
Graeme Young

GlaxoSmithKline Research and Development Ltd.,

UK
H. Leonhard Ohrem

Merck Millipore

Germany
Achyut Khire

Institute of Chemical Technology

India
Ravi Kanneti

Dr. Reddys Laboratories Ltd

India
Peisheng Xu

University of South Carolina

USA
Dong Xiao

University of Pittsburgh

USA
Shawn X. Yin

Bristol-Myers Squibb Company

USA
Conference: BABE-2013, Conference Series Conferences
35 Ruddlesway, Windsor,Berkshire, SL4 5SF
Contact:
Toll free: 0044-2033180199(USA & Canada),
0044-2033180199(Australia), 0044-2033180199(Europe)
Operated by: Editors - Journal of Bioequivalence & Bioavailability, Journal of Bioanalysis & Biomedicine and Pharmaceutica Analytica Acta
The Organizers reserve the rights to make changes and adjustment to the information in this website
Copyright 2023 Conference Series - All rights reserved